Charles Explorer logo
🇬🇧

Current treatment of chronic myeloid leukemia - tyrosinkinas inhibitors.

Publication at First Faculty of Medicine |
2012

Abstract

Chronic myeloid leukemia (CML) is the most common disease from the group of myeloproliferative diseases, represents 15-20% of newly diagnosed leukemias. The cause of the disease is the transformation of pluripotent hematopoietic cell.